TRANSMEDICS GROUP INC (TMDX)
US89377M1099 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-28) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -25.03M | -36.23M | -44.22M | -28.75M | -33.55M | |||
| Depreciation Amortization | 8.18M | 3.48M | 1.82M | 1.58M | 1.22M | |||
| Income Taxes - Deferred | -1.66M | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -44.35M | -26.76M | 3.00M | -5.59M | -1.63M | |||
| Interest Paid | 8.09M | 3.26M | 3.33M | 3.48M | 3.88M | |||
| Other non cash items | 49.83M | 13.70M | 10.53M | 2.49M | 1.67M | |||
| OPERATING CASH FLOW | -13.03M | -45.82M | -28.86M | -30.27M | -32.29M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -151.85M | -11.91M | -3.52M | -460.00K | -170.00K | |||
| Other Investing Activity | -42.11M | 66.42M | 32.79M | -41.14M | -60.34M | |||
| INVESTING CASH FLOW | -193.95M | 54.51M | 29.27M | -41.60M | -60.50M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 393.31M | 22.46M | 0.00 | 0.00 | N/A | |||
| Stock Issued/Repurchased | 7.11M | 145.47M | 1.39M | 76.25M | 200.00K | |||
| Other Financing Activity | N/A | N/A | 0.00 | -710.00K | 92.52M | |||
| FINANCING CASH FLOW | 400.42M | 167.93M | 1.39M | 75.55M | 92.72M | |||
| Exchange Rate Effect | 193.00K | -1.02M | -800.00K | 800.00K | -90.00K | |||
| CHANGE IN CASH | 193.63M | 175.60M | 1.00M | 4.48M | -160.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -13.03M | -45.82M | -28.86M | -30.27M | -32.29M | |||
| Capital Expenditure | -151.85M | -11.91M | -3.52M | -460.00K | -170.00K | |||
| FREE CASH FLOW | -164.88M | -57.73M | -32.38M | -30.73M | -32.46M | |||
All data in USD